Transformed mycosis fungoides: bridging to allogeneic stem cell transplantation with brentuximab vedotin
Although mycosis fungoides (MF) is characterized by an indolent course of disease (disease specific 5 year survival rate of up to 88% disease progression or death occurs in nearly 30% of MF patie.
Leukemia lymphoma